Search
for
Sort by
Research 331–360 of 1000+
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Resident Memory T Cells in Autoimmune Skin Diseases
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Genome-Wide Association Study of Alopecia Areata in Taiwan: The Conflict Between Individuals and Hair Follicles
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Review of Promising Off-Label Use of Deucravacitinib
- Intrinsic Modulators of Hair Growth: Roles of Growth Factors, Cytokines, Chemokines, and Interferons
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Pathogenesis and regenerative therapy in vitiligo and alopecia areata: focus on hair follicle
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- New and Emerging Therapies for Alopecia Areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Expression profile analysis of dermal papilla cells mRNA in response to WNT10B treatment
- Mechanisms of autophagy and their implications in dermatological disorders